H. R. 1632 aims to modify the Federal Food, Drug, and Cosmetic Act to allow for the reciprocal marketing of certain drugs, biological products, and devices approved in other countries, including those listed under section 802(b)(1) and the United Kingdom. It outlines...
Simple Explanation
H. R. 1632 is a plan to let certain medicines and medical tools approved in other countries be sold in the U.S. quickly, as long as they are safe and have not been removed from the market for safety reasons. The idea is to make new treatments available sooner, but some people worry it might not give U.S. officials enough time to check if they are really safe.